Article metrics

Download PDFPDF

Original research
Characterisation of the safety profile of evobrutinib in over 1000 patients from phase II clinical trials in multiple sclerosis, rheumatoid arthritis and systemic lupus erythematosus: an integrated safety analysis

 

Online download statistics by month:

Online download statistics by month: November 2022 to November 2022

AbstractFullPdf
Nov 2022803534145
Total803534145